Login to Your Account

Hybrigenics Gets €1.4M for Inecalcitol in Prostate Cancer

By Staff Reports

Wednesday, September 10, 2008

No Abstract

PARIS - Hybrigenics SA has been granted a refundable subsidy of €1.4 million (US$2 million) by France's state agency for promoting innovation and supporting small and medium-sized enterprises, OSEO, to finance the development of inecalcitol as a treatment for prostate cancer.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription